Precigen vs Xencor
PGEN and XNCR side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How PGEN and XNCR compare
Xencor is the larger company, worth 1.7 times as much as Precigen ($2.6B against $1.5B).
Xencor scores higher on the StockData Score (5 against 2 for Precigen), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | PGEN | XNCR |
|---|---|---|
| Size and price | ||
| Market cap | $1.5B | $2.6B |
| Share price | $4.30 | $35.40 |
| Change, 1 year | 11.4% | 153% |
| Change, 5 years | 11.4% | −0.11% |
| Beta (5Y) | 1.20 | −0.09 |
| Employees | 20 | 260 |
| StockData Score | ||
| Total score | 2 | 5 (better) |
| Valuation score | 0 | 0 |
| Growth score | 0 | 1 (better) |
| Performance score | 0 | 1 (better) |
| Health score | 2 | 3 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | – | 25.1× |
| P/B | 35.3× | 5.2× (better) |
| FCF yield | −7.5% (better) | −7.9% |
| Fair value | – | $11.73 |
| Margin of safety | – | −202% |
| Growth | ||
| Revenue growth (TTM) | – | −28.6% |
| Revenue growth, 5Y average | −21.3% | 0.47% (better) |
| Profitability | ||
| Operating margin | – | −206% |
| Net margin | – | −156% |
| FCF margin | – | −198% |
| Return on equity | −4640% | −29.1% (better) |
| Return on invested capital | – | −26.6% |
| Financial health | ||
| Debt / equity | 2.15 | 0.21 (better) |
| Interest coverage | – | −8.0× |
| Current ratio | 4.58 | 6.39 (better) |
| Altman Z-score | −11.12 | 5.19 (better) |
| Piotroski F-score | 2 | 3 (better) |
| Dividends and buybacks | ||
| Buyback yield | 0.00% | – |
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 39.2% | 113% |
| Held by insiders | 44.9% | 1.6% |
| Insider net buying, 12 months | −$32.5M | −$7.5M (better) |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 22.8% | 17.6% |
Go deeper
- PGEN stock overview
- PGEN income statement
- PGEN valuation and score
- XNCR stock overview
- XNCR income statement
- XNCR valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.